Encorafenib
Records for this ingredient, by country (identity only).
ATC L01EC03 · 12 markets · 23 records
AU 5 records · 2 shown of 2
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
SG 2 records · 2 shown of 2
- 75 mgcapsuleBraftovi 75 mg hard capsules
- 50 mgcapsuleBraftovi 75 mg hard capsules
HK 2 records · 0 shown of 0
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 2 records · 2 shown of 2
- 75 mgcapsuleビラフトビカプセル75mg
- 50 mgcapsuleビラフトビカプセル75mg
FR 2 records · 2 shown of 2
- 75 mgcapsuleBRAFTOVI 75 mg, gélule
- 50 mgcapsuleBRAFTOVI 50 m,g gélule
US 1 records · 1 shown of 1
- 75 mgcapsuleBRAFTOVI
CA 1 records · 1 shown of 1
- 75 mgcapsuleBRAFTOVI
MX 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 1 records · 1 shown of 1
- 75 mgcapsuleBraftovi 75 mg hard capsules迫癌癒 75 毫克膠囊
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | TW | HK | JP | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75 mg capsule | BRAFTOVI | BRAFTOVI | BRAFTOVI | BRAFTOVI BRAFTOVI encorafenib 75 mg capsule blister pack | Braftovi 75 mg hard capsules | BRAFTOVI | Braftovi 75 mg hard capsules 迫癌癒 75 毫克膠囊 | ビラフトビカプセル75mg | BRAFTOVI 75 mg, gélule | |||
| 50 mg capsule | BRAFTOVI | BRAFTOVI BRAFTOVI encorafenib 75 mg capsule blister pack | Braftovi 75 mg hard capsules | BRAFTOVI | ビラフトビカプセル75mg | BRAFTOVI 50 m,g gélule | ||||||
unknown | BRAFTOVI | BRAFTOVI | BRAFTOVI | |||||||||
capsule | BRAFTOVI |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in MX and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en MX que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 MX 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 MX 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.